Avasimibe and Sirt 1 Activators Reverse NAFLD and Obesity.

Ian James Martins

Avasimibe and Sirt 1 Activators Reverse NAFLD and Obesity.

Ian James Martins

UWA Medical School

Research output: Contribution to journal › Editorial › peer-review

87 Downloads (Pure)

Abstract

Healthy diets and its therapeutic use in obesity and diabetes may be ineffective with relevance to drug induced mitophagy. Avasimibe and its use with other Sirt 1 activators have become of importance to drug therapy in obesity and diabetes with relevance to the acceleration of hepatic drug metabolism with the prevention of mitochondrial apoptosis. The use of synthetic Sirt 1 activators with healthy diets may prevent brain disease and NAFLD that are associated with the induction of global obesity linked diabetes.

Original language	English
Pages (from-to)	1-2
Number of pages	2
Journal	Novel Approaches in Drug Designing & Development
Volume	1
Issue number	3
Publication status	Published - 2 Jun 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

NAPDD.MS.ID.555561Final published version, 390 KB

Cite this

@article{d688cd084dc048ef8439c62f93eece10,

title = "Avasimibe and Sirt 1 Activators Reverse NAFLD and Obesity.",

abstract = "Healthy diets and its therapeutic use in obesity and diabetes may be ineffective with relevance to drug induced mitophagy. Avasimibe and its use with other Sirt 1 activators have become of importance to drug therapy in obesity and diabetes with relevance to the acceleration of hepatic drug metabolism with the prevention of mitochondrial apoptosis. The use of synthetic Sirt 1 activators with healthy diets may prevent brain disease and NAFLD that are associated with the induction of global obesity linked diabetes.",

author = "Martins, {Ian James}",

year = "2017",

month = jun,

day = "2",

language = "English",

volume = "1",

pages = "1--2",

journal = "Novel Approaches in Drug Designing & Development",

issn = "2575-8942",

publisher = "Juniper Publishers",

number = "3",

}

TY - JOUR

T1 - Avasimibe and Sirt 1 Activators Reverse NAFLD and Obesity.

AU - Martins, Ian James

PY - 2017/6/2

Y1 - 2017/6/2

N2 - Healthy diets and its therapeutic use in obesity and diabetes may be ineffective with relevance to drug induced mitophagy. Avasimibe and its use with other Sirt 1 activators have become of importance to drug therapy in obesity and diabetes with relevance to the acceleration of hepatic drug metabolism with the prevention of mitochondrial apoptosis. The use of synthetic Sirt 1 activators with healthy diets may prevent brain disease and NAFLD that are associated with the induction of global obesity linked diabetes.

AB - Healthy diets and its therapeutic use in obesity and diabetes may be ineffective with relevance to drug induced mitophagy. Avasimibe and its use with other Sirt 1 activators have become of importance to drug therapy in obesity and diabetes with relevance to the acceleration of hepatic drug metabolism with the prevention of mitochondrial apoptosis. The use of synthetic Sirt 1 activators with healthy diets may prevent brain disease and NAFLD that are associated with the induction of global obesity linked diabetes.

M3 - Editorial

SN - 2575-8942

VL - 1

SP - 1

EP - 2

JO - Novel Approaches in Drug Designing & Development

JF - Novel Approaches in Drug Designing & Development

IS - 3

ER -

Avasimibe and Sirt 1 Activators Reverse NAFLD and Obesity.

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this